semaglutide nausea lawsuit in louisiana class action Woman sues drug makers of Ozempic and Mounjaro over severe gastrointestinal issues semaglutide vomiting semaglutide vomiting lawsuit in louisiana

It belongs to a class of drugs, sometimes called peptides for weight loss. Tirzepatide is not only a GLP-1 receptor agonist

It can be given at any time of day, and you can take it with or without food

Abstract Neurodegenerative diseases are characterized by progressive neuronal dysfunction, often accompanied by chronic inflammatory states and redox imbalance within the central nervous system (CNS)

The FDA classified the recall as Class II, affecting multiple strengths with expiration dates from February to October 2026

Autolus backed Aucatzyl with data from the Phase II FELIX study, which showed a 63% overall complete remission rate, including 51% of patients who achieved complete remission

Additionally, the study was conducted in vitro (outside the body) as opposed to in vivo (in the body), which would give us a better understanding of how sucralose or any metabolites affect our health